🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaowei Liu

Jiangsu University

ORCID: 0000-0002-1193-4277

Also affiliated with Central South University, Dalian Institute of Chemical Physics, Yantai University, Chinese Academy of Sciences, Sichuan University, The Fourth People's Hospital, Fourth People's Hospital of Sichuan Province, Dalian Municipal Central Hospital, Precision for Medicine (United States), Beijing Anzhen Hospital, National Clinical Research, Shanghai East Hospital, Xiangya Hospital Central South University, University of Chinese Academy of Sciences, Dalian Jiaotong University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial”.

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30023-1

N/A

5.0DataRank · unranked

337 citations

Elizabeth Fox, Melinda S. Merchant, Joel M. Reid, Rachel A. Kudgus, Xiaowei Liu +6 more

Predicting the role of the human gut microbiome in type 1 diabetes using machine-learning methods

Briefings in Functional Genomics(2024)10.1093/bfgp/elae004

N/A

0.396DataRank · unranked

13 citations

Han-Lin Li, Cai-Yi Ma, Tian-Yu Shi, Tian-Yu Wang, Dan Yan +9 more

A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase‐Clinical Trial Network (PEP‐CTN)

Pediatric Blood & Cancer(2021)10.1002/pbc.28892

N/A

0DataRank · unranked

38 citations

Bill H. Chang, Joel M. Reid, Xiaowei Liu, Charles G. Minard, Jane B. Trepel +4 more

Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart

PLoS ONE(2021)10.1371/journal.pone.0257280

N/A

0DataRank · unranked

11 citations

Kevin Kline, Xiaoying S. Zhong, Ying Xiao, Haifeng Lian, Jun Peng +5 more

Phase 1 study of pevonedistat (MLN4924) a NEDD8 activating enzyme inhibitor, in combination with temozolomide (TMZ) and irinotecan (IRN) in pediatric patients with recurrent or refractory solid tumors (ADVL1615).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10019

N/A

0DataRank · unranked

3 citations

Joel M. Reid, Charles G. Minard, Emasenyie Isikwei, Xiaowei Liu, Stacey L. Berg +4 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10018

N/A

0DataRank · unranked

0 citations

Xiaowei Liu, Charles G. Minard, Sarah Menig, Joel M. Reid, Emasenyie Isikwei +6 more

Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7

Frontiers in Immunology(2022)10.3389/fimmu.2022.1020902

N/A

0DataRank · unranked

57 citations

Haifeng Lian, Xiaoying S. Zhong, Srikruthi S. Krishnachaitanya, Yingzi Cong, Roderick H. Dashwood +5 more

Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children’s Oncology Group phase I consortium study

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac073

N/A

0DataRank · unranked

16 citations

Tabitha Cooney, Xiaodong Yang, Sharmistha Pal, Ralph P. Ermoian, Amar Gajjar +9 more

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma

Cancer(2023)10.1002/cncr.34786

N/A

0DataRank · unranked

32 citations

Heba Ijaz, Lea F. Surrey, Mariarita Santi, Xiaowei Liu, Charles G. Minard +6 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712

Pediatric Blood & Cancer(2023)10.1002/pbc.30672

N/A

0DataRank · unranked

3 citations

Xiaowei Liu, Charles G. Minard, Emasenyie Isikwei, Joel M. Reid, Terzah M. Horton +4 more

A phase 1/2 study of bay 18953444 (Elimusertib) in pediatric patients with relapsed or refractory solid tumors: Initial report of the phase 1 results of PEPN2112.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15131

N/A

0DataRank · unranked

9 citations

Julia Glade Bender, Charles G. Minard, Xiaowei Liu, Kristina Z. Denic, Joel M. Reid +8 more

Cycling Stem Cells Are Radioresistant and Regenerate the Intestine

Cell Reports(2020)10.1016/j.celrep.2020.107952

N/A

0DataRank · unranked

66 citations

Ziguang Lin, Cong Lv, Chunlei Shao, Xueyun Bi, Min Deng +21 more